GlassScriptPhysician profile
Bianca E Roman
NPI 1053824532
$631.02
in general payments reported to CMS, 2019-2025
10 companies · $152 in 2025
The $152 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $162 · 2023: $112 · 2024: $31.22 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Y-Mabs Therapeutics, INC. | $123.38 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $112.34 | 2023-2025 | Dysport |
| Jazz Pharmaceuticals INC. | $95.12 | 2022-2023 | |
| Genzyme Corporation | $92.06 | 2021 | |
| United Therapeutics Corporation | $63.26 | 2022 | |
| Abbvie INC. | $62.46 | 2024-2025 | |
| Servier Pharmaceuticals LLC | $24.54 | 2022 | |
| Amneal Pharmaceuticals LLC | $22.25 | 2023 | Lyvispah |
| 180 Medical, INC. | $19.25 | 2025 | |
| Vertical Pharmaceuticals, LLC | $16.36 | 2025 | Relexxii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Roman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.